ÐÓ°ÉÊÓƵ

Recently, we had the opportunity to speak with Robin Mansukhani, the founder and CEO of Deciduous Therapeutics, a San Francisco-based biotechnology company focused on restoring immune function to combat diseases of aging. Deciduous Therapeutics is pioneering the use of the body’s own immune system t...

Recently we had a conversation with Shardule Shah, CEO and founder of Lime Therapeutics, a company dedicated to advancing therapies for diseases related to dysfunctional lipid metabolism. By leveraging their innovative LipidSense platform, Lime Therapeutics is transforming the way we understand and ...

Peter Galen (CIT ’76) is the CIO and co-founder of Hemex Health, an Oregon-based medical device company developing a more affordable and robust blood disease diagnostic platform. Their flagship product, Gazelle, is an affordable point-of-care diagnostic tool that uses electrophoresis to test for a v...

Mark Day, CEO of ÐÓ°ÉÊÓƵ spinout AlensiaXR, recently sat down with us to discuss his journey from Microsoft to leading a cutting-edge mixed reality startup. With over 18 years of experience at Microsoft and a background in entrepreneurship, Mark offers unique insights into le...

Recently, we had the privilege to chat with Charu Ramanathan, PhD (GRS ‘04), a serial entrepreneur driven by a passion for leveraging technology to advance health equity and access. Her journey from a PhD student to a successful founder of multiple companies offers valuable insights for aspiring ent...

John Dulin (CWR ‘15) is the CEO and founder of Modern Intelligence, a Texas-based defense startup developing an autonomous targeting platform. Their first product, CUTLASS, uses cutting edge proprietary AI and ML algorithms to identify and track a variety of types of potential threats on the battlef...